Continuous flow-through peritoneal dialysis (CFPD) method with control of intraperitoneal pressure
AssigneeRenal Solutions, Inc.
InventorStephen R. Ash
Life of this patent
Estimating the term…
Loading patent…
AssigneeRenal Solutions, Inc.
InventorStephen R. Ash
Estimating the term…
The present invention relates generally to advantageous devices and methods for treating patients suffering from renal insufficiency and/or hepatic insufficiency. More particularly, the invention relates in certain aspects to devices and methods for performing continuous flow-through peritoneal dialysis (CFPD). In other aspects of the invention, peritoneal dialysis systems are provided which utilizes a bioreactor to regenerate peritoneal fluid for re-infusion into a peritoneal cavity. The invention, therefore, provides advantageous systems for passing fluid through a patient's peritoneal cavity at a relatively high flow rate, while maintaining in the peritoneal cavity an optimal dialysate pressure, to thereby alter the contents of the patient's blood by diffusion of molecules through the peritoneal membrane.
A device for performing continuous flow peritoneal dialysis, comprising:
A device for performing continuous flow peritoneal dialysis, comprising:
A method for removing toxins from a patient's blood, comprising:
A method for removing toxins from a patient's blood, comprising:
A device for performing continuous flow peritoneal dialysis, comprising:
A device for performing continuous flow peritoneal dialysis, comprising:
A method for removing toxins from a patient's blood, comprising:
A device for treating a patient for hepatic insufficiency, comprising:
A device for treating a patient for hepatic insufficiency, comprising:
A method for treating a patient for hepatic insufficiency, comprising:
A method for treating a patient for hepatic insufficiency, comprising:
A continuous flow peritoneal dialysis system comprising:
A process for performing continuous flow peritoneal dialysis, comprising:
Dependencies are inferred from the claim text.